Yellow Potatoes and Carotenoids
Effects of Yellow Flesh Potatoes on Carotenoid Status
1 other identifier
interventional
30
1 country
1
Brief Summary
This study will assess the effects of daily intake of yellow and white potatoes on plasma lutein and zeaxanthin concentrations. Skin carotenoid levels will be assessed using the Veggie Meter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2026
CompletedFirst Posted
Study publicly available on registry
May 26, 2026
CompletedStudy Start
First participant enrolled
May 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
June 11, 2026
May 1, 2026
3 months
May 18, 2026
June 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma zeaxanthin
Plasma concentration of zeaxanthin
28 days
Secondary Outcomes (2)
Plasma lutein
28 days
Skin carotenoid content
28 days
Study Arms (2)
Yellow-flesh potatoes
EXPERIMENTAL250 g of yellow-flesh potatoes
White-flesh potatoes
PLACEBO COMPARATOR250 g of white-flesh potatoes
Interventions
Participants will consume 250 g daily of yellow-flesh potatoes.
Participants will consume 250 g daily of white-flesh potatoes.
Eligibility Criteria
You may qualify if:
- Adults ≥ 18 years of age
- Able to provide written consent in English
- Baseline Veggie Meter score of ≤ 300
- Willing to adhere to study procedures
You may not qualify if:
- Baseline Veggie Meter score of \>300
- Potato allergy
- Previously or currently being treated for intestinal disease, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, celiac disease, or gastrointestinal cancer
- Previous gastrointestinal surgery (e.g., gastric bypass, fundoplication, bowel resection)
- Current cancer treatment
- Current pregnancy; Vegetarian diet
- Elite athletes or long-distance runners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32611, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2026
First Posted
May 26, 2026
Study Start
May 28, 2026
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
June 11, 2026
Record last verified: 2026-05